0,967  0,003  Eye irritation, high
0,951  0,003  Skin irritative effect
0,771  0,004  5 Hydroxytryptamine release stimulant
0,771  0,007  GST A substrate
0,774  0,010  Teratogen
0,762  0,010  Embryotoxic
0,715  0,010  Carcinogenic
0,700  0,006  Cardiovascular analeptic
0,675  0,005  5 Hydroxytryptamine release inhibitor
0,664  0,011  Aldehyde oxidase inhibitor
0,662  0,013  Respiratory analeptic
0,651  0,012  Cholesterol antagonist
0,634  0,008  Lipoprotein disorders treatment
0,642  0,019  TNF expression inhibitor
0,626  0,011  CTGF expression inhibitor
0,620  0,011  Immunosuppressant
0,601  0,005  FMO1 substrate
0,602  0,013  Analeptic
0,590  0,004  UGT2B1 substrate
0,587  0,015  Mutagenic
0,586  0,016  Sensitization
0,583  0,013  Antipruritic, allergic
0,582  0,018  Vasodilator, peripheral
0,565  0,009  UDP-glucuronosyltransferase substrate
0,558  0,005  Anesthetic general
0,563  0,017  Radioprotector
0,549  0,006  Antiseptic
0,554  0,016  Histamine release inhibitor
0,540  0,010  Hypolipemic
0,563  0,042  Caspase 9 stimulant
0,541  0,021  CYP2C19 substrate
0,525  0,023  Antihypercholesterolemic
0,512  0,020  Antifungal
0,497  0,005  Alpha-N-acetylglucosaminidase inhibitor
0,501  0,009  Peroxidase inhibitor
0,490  0,007  Septic shock treatment
0,529  0,047  Antiarthritic
0,482  0,003  Succinate dehydrogenase inhibitor
0,484  0,008  Hair growth stimulant
0,478  0,005  Amyloid beta precursor protein antagonist
0,476  0,007  Abortion inducer
0,469  0,007  Antiparkinsonian, rigidity relieving
0,486  0,025  Spasmolytic
0,482  0,022  NOS3 expression inhibitor
0,469  0,016  Superoxide dismutase inhibitor
0,479  0,028  Ulceration
0,463  0,017  UGT2B4 substrate
0,457  0,025  Antihypertensive
0,439  0,009  Carcinogenic, group 3
0,441  0,013  Wound healing agent
0,454  0,036  Bone diseases treatment
0,424  0,008  Antipruritic, non-allergic
0,453  0,036  Immunostimulant
0,416  0,007  GST P1-1 substrate
0,433  0,027  NOS2 expression inhibitor
0,409  0,003  Alcohol dehydrogenase substrate
0,439  0,046  GABA C receptor rho-3 antagonist
0,414  0,023  Cardiodepressant
0,416  0,027  Proliferative diseases treatment
0,396  0,011  Phospholipase C inhibitor
0,389  0,006  CNS active muscle relaxant
0,418  0,038  Hepatic disorders treatment
0,439  0,061  Antibacterial
0,422  0,044  Antithrombotic
0,412  0,034  Antiosteoporotic
0,375  0,004  Antispirochetal
0,384  0,015  GST M1-1 substrate
0,379  0,013  Antiacne
0,372  0,009  Antiparkinsonian, tremor relieving
0,397  0,035  Chemoprotective
0,372  0,010  Acaricide
0,401  0,039  AR expression inhibitor
0,369  0,010  Protein kinase stimulant
0,381  0,024  Sodium/bile acid cotransporter inhibitor
0,386  0,032  Radiosensitizer
0,358  0,004  Catalase inhibitor
0,369  0,017  Antiviral (Herpes)
0,375  0,025  Antihypertriglyceridemic
0,381  0,033  Interleukin 2 agonist
0,389  0,045  Antipsoriatic
0,403  0,062  CYP2C9 substrate
0,369  0,028  FMO3 substrate
0,353  0,015  Tyrosine 3 hydroxylase inhibitor
0,364  0,026  Flavin-containing monooxygenase substrate
0,366  0,029  Vasodilator
0,346  0,009  Glutathione S-transferase substrate
0,356  0,024  5 Hydroxytryptamine uptake stimulant
0,353  0,022  UGT1A4 substrate
0,339  0,008  Antihyperlipoproteinemic
0,414  0,084  Cyclophilin D inhibitor
0,414  0,084  Antidiabetic
0,341  0,013  Gastrin inhibitor
0,334  0,007  Aldose reductase substrate
0,345  0,018  UGT2B7 substrate
0,353  0,030  DNA synthesis inhibitor
0,364  0,043  UGT1A9 substrate
0,437  0,117  Antiinflammatory
0,323  0,004  Toll-Like receptor 2 antagonist
0,326  0,008  UGT2B9 substrate
0,333  0,016  Interferon gamma antagonist
0,331  0,017  Skeletal muscle relaxant
0,317  0,003  Prostaglandin F2 alpha antagonist
0,381  0,068  CYP3A4 substrate
0,360  0,051  Vasodilator, coronary
0,312  0,005  Phosphofructokinase-1 inhibitor
0,350  0,044  Antidiabetic (type 2)
0,327  0,023  Antihypotensive
0,330  0,026  Muscle relaxant
0,322  0,020  VCAM1 expression inhibitor
0,311  0,010  Cholesterol synthesis inhibitor
0,336  0,035  Antiparasitic
0,345  0,044  Antineurogenic pain
0,335  0,037  Angiogenesis stimulant
0,342  0,044  Cytotoxic
0,337  0,041  Hypoglycemic
0,316  0,021  Thrombolytic
0,327  0,034  Anticonvulsant
0,334  0,042  Tumour necrosis factor alpha release inhibitor
0,325  0,037  Interleukin agonist
0,307  0,025  Antimutagenic
0,356  0,075  Transcription factor NF kappa B inhibitor
0,288  0,006  UGT2B10 substrate
0,309  0,030  Antihelmintic
0,327  0,048  Antipyretic
0,310  0,031  Platelet adhesion inhibitor
0,282  0,006  Constipation treatment
0,281  0,004  Aldehyde dehydrogenase substrate
0,305  0,029  Antiviral (Influenza)
0,314  0,039  Psychostimulant
0,296  0,024  Pneumotoxic
0,350  0,078  Stroke treatment
0,289  0,018  Genotoxic
0,276  0,007  Selectin antagonist
0,286  0,020  Amylase inhibitor
0,273  0,011  Uterine stimulant
0,266  0,005  Alcohol oxidase inhibitor
0,284  0,024  Melanin inhibitor
0,270  0,010  Antiviral (Poxvirus)
0,319  0,061  Antineoplastic (pancreatic cancer)
0,271  0,014  DNA polymerase I inhibitor
0,279  0,025  CYP2B6 inhibitor
0,305  0,051  Platelet antagonist
0,272  0,021  Bone formation stimulant
0,251  0,005  Arachidonic acid antagonist
0,252  0,007  Antirickettsial
0,246  0,002  Antiviral (Parainfluenza)
0,251  0,007  Coagulant
0,243  0,004  Sphingosine 1-phosphate receptor 5 antagonist
0,254  0,015  Cell wall synthesis inhibitor
0,275  0,037  Growth hormone agonist
0,275  0,038  RNA-directed DNA polymerase inhibitor
0,249  0,012  Antiviral (Ebola)
0,263  0,026  Anesthetic
0,246  0,010  Adenylate kinase inhibitor
0,263  0,028  UGT1A3 substrate
0,240  0,005  Ornithine carbamoyltransferase inhibitor
0,245  0,011  Retinoprotector
0,262  0,028  Insulin sensitizer
0,237  0,004  Sphingosine 1-phosphate receptor 2 antagonist
0,304  0,074  Antiischemic
0,269  0,042  Sedative
0,256  0,030  Diuretic
0,249  0,023  Acute respiratory distress syndrome (ARDS) treatment
0,238  0,015  GABA C receptor agonist
0,274  0,052  UGT1A6 substrate
0,237  0,015  Ferrochelatase inhibitor
0,256  0,035  Neurotrophic factor enhancer
0,287  0,067  Antioxidant
0,239  0,020  Aldehyde dehydrogenase inhibitor
0,301  0,081  CYP2D6 substrate
0,238  0,020  Carcinogenic, group 1
0,241  0,026  Antidote
0,219  0,005  Interferon agonist
0,219  0,007  Sphingomyelinase inhibitor
0,245  0,033  Antihelmintic (Nematodes)
0,217  0,007  Argininosuccinate synthase inhibitor
0,238  0,028  Antiviral (Influenza A)
0,233  0,024  Anesthetic local
0,248  0,038  Antiviral (West Nile virus)
0,217  0,010  Photosensitizer
0,209  0,003  Ca2+-transporting ATPase inhibitor
0,231  0,025  Neurotensin receptor agonist
0,222  0,017  Aminopeptidase B inhibitor
0,223  0,019  Neurotrophic factor
0,214  0,010  GABA C receptor antagonist
0,239  0,037  Antiviral (Hepatitis)
0,210  0,009  Creatine kinase inhibitor
0,251  0,052  Chemopreventive
0,209  0,010  Triose-phosphate isomerase inhibitor
0,216  0,017  Excitatory amino acid transporter EAAC1 inhibitor
0,227  0,030  Phospholipase A2 inhibitor
0,292  0,095  ICAM1 expression inhibitor
0,201  0,004  Glycine receptor agonist
0,201  0,005  GST T1-1 substrate
0,228  0,032  Muscular dystrophy treatment
0,227  0,032  Thiol protease inhibitor
0,204  0,011  Vanilloid 1 agonist
0,287  0,094  Apoptosis antagonist
0,197  0,005  Acyl-CoA dehydrogenase inhibitor
0,304  0,112  Calpain 2 inhibitor
0,198  0,006  Toll-Like receptor 4 antagonist
0,208  0,017  Antifungal (Cryptococcus)
0,282  0,093  Immunomodulator
0,201  0,013  Adenylate cyclase stimulant
0,269  0,082  Antihypoxic
0,195  0,007  CDC25A inhibitor
0,211  0,028  Antifungal enhancer
0,193  0,010  Prolactin inhibitor
0,234  0,050  Non-steroidal antiinflammatory agent
0,239  0,059  Peptidyltransferase inhibitor
0,282  0,103  Thyroid hormone antagonist
0,217  0,038  Antipruritic
0,230  0,052  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,202  0,025  Raynaud's phenomenon treatment
0,180  0,003  Anesthetic inhalation
0,186  0,010  Electron transport complex I inhibitor
0,191  0,015  Contraceptive female
0,245  0,069  Cytostatic
0,210  0,034  Corneal wound healing stimulator
0,180  0,007  UGT2B11 substrate
0,180  0,007  Antidote, mercury
0,179  0,007  Paget's disease treatment
0,202  0,029  SULT1A3 substrate
0,245  0,073  Antiamyloidogenic
0,185  0,013  Sphingosine 1-phosphate receptor 4 antagonist
0,193  0,021  Cyclooxygenase 3 inhibitor
0,171  0,004  Aconitate hydratase inhibitor
0,189  0,022  Microtubule formation inhibitor
0,205  0,039  Antiviral (Hepatitis C)
0,167  0,002  Glucose-6-phosphate isomerase inhibitor
0,187  0,022  SULT1A1 substrate
0,180  0,015  Antiviral (Influenza B)
0,188  0,025  Antineoplastic antimetabolite
0,181  0,018  Mediator release inhibitor
0,183  0,021  UDP-glucose 4-epimerase inhibitor
0,231  0,069  Interleukin antagonist
0,198  0,037  Insulin secretagoues
0,201  0,042  Aldehyde oxidase substrate
0,178  0,019  Mucolytic
0,232  0,074  Neuropeptide Y2 antagonist
0,198  0,041  Antineoplastic (bone cancer)
0,176  0,020  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,166  0,010  Carbamoyl phosphate synthetase inhibitor
0,235  0,079  Calpain inhibitor
0,168  0,012  Keratolytic
0,253  0,097  CYP1A2 substrate
0,225  0,072  Antiulcerative
0,215  0,063  UGT1A1 substrate
0,156  0,004  Interferon inducer
0,160  0,009  Ornithine decarboxylase inhibitor
0,223  0,073  Antiviral (HIV)
0,249  0,099  Antiepileptic
0,182  0,031  Proteasome inhibitor
0,272  0,122  Calcium channel activator
0,164  0,014  ABCA1 expression enhancer
0,229  0,080  Antiglaucomic
0,169  0,022  Antineoplastic, alkylator
0,175  0,031  Cathepsin H inhibitor
0,193  0,050  Prostate disorders treatment
0,183  0,041  Nav1.2 sodium channel blocker
0,152  0,010  Lanosterol 14 alpha demethylase inhibitor
0,263  0,122  Antineoplastic (small cell lung cancer)
0,146  0,004  Estrogen-related receptor beta agonist
0,145  0,004  Glutamate (mGluR6) antagonist
0,151  0,011  Toll-Like receptor 2 agonist
0,188  0,049  ATPase inhibitor
0,157  0,018  GABA C receptor rho-1 antagonist
0,151  0,012  Aminopeptidase I inhibitor
0,143  0,006  Neuraminidase inhibitor
0,196  0,059  Lipocortins synthesis antagonist
0,224  0,088  Antineoplastic (liver cancer)
0,146  0,012  Restless leg syndrome treatment
0,165  0,031  Pregnane X receptor agonist
0,170  0,037  Nav1.3 sodium channel blocker
0,144  0,011  Glutamate release inhibitor
0,162  0,031  Expectorant
0,148  0,019  Anabolic
0,150  0,021  Actinic keratosis treatment
0,145  0,017  Glutamate dehydrogenase inhibitor
0,179  0,052  UGT2B15 substrate
0,193  0,066  Myocardial ischemia treatment
0,174  0,047  GABA C receptor rho-2 antagonist
0,235  0,111  Insulysin inhibitor
0,135  0,011  Glycine receptor antagonist
0,135  0,012  Sphingosine 1-phosphate receptor 4 agonist
0,162  0,040  Antiviral (Hepatitis B)
0,153  0,032  Choleretic
0,130  0,010  Neuraminidase (influenza) inhibitor
0,151  0,030  TRPA1 agonist
0,295  0,175  Apoptosis agonist
0,124  0,005  Gaucher disease treatment
0,144  0,026  Antifungal (Pneumocystis)
0,160  0,042  Alkylator
0,134  0,017  Glutamate decarboxylase inhibitor
0,137  0,021  NADH dehydrogenase inhibitor
0,122  0,006  Vanilloid 4 agonist
0,189  0,075  VEGF expression inhibitor
0,119  0,005  Sphingosine kinase 2 inhibitor
0,158  0,044  Monophenol monooxygenase inhibitor
0,152  0,038  Carcinogenic, group 2B
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,124  0,012  Antiviral (Hepatitis A)
0,142  0,030  Antiinfertility, female
0,116  0,005  Sphingosine kinase inhibitor
0,116  0,005  Alpha-mannosidase inhibitor
0,200  0,089  Nitric-oxide synthase stimulant
0,144  0,033  Caspase 3 inhibitor
0,125  0,016  Vanilloid agonist
0,220  0,111  Transcription factor STAT3 inhibitor
0,175  0,067  Toxic, respiratory center
0,127  0,019  Antifungal (Candida)
0,112  0,004  Squalene epoxidase inhibitor
0,177  0,069  Tumour necrosis factor antagonist
0,114  0,006  Glucosylceramidase inhibitor
0,127  0,019  Glutathione S-transferase inhibitor
0,140  0,035  Anticataract
0,308  0,203  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,148  0,043  Growth stimulant
0,160  0,057  Antiprotozoal (Coccidial)
0,113  0,010  Endocannabinoid uptake inhibitor
0,115  0,012  CDC25B inhibitor
0,125  0,023  Metalloproteinase-9 inhibitor
0,181  0,079  Hepatoprotectant
0,111  0,010  Antiviral (Herpesvirus 3, Human)
0,135  0,034  Antineoplastic antibiotic
0,166  0,065  Antianorexic
0,141  0,041  Falcipain 3 inhibitor
0,230  0,131  Thyroid hormone beta antagonist
0,138  0,039  Antischistosomal
0,128  0,030  Androgen antagonist
0,133  0,035  Estrogen antagonist
0,108  0,010  Antidote, organophosphates
0,138  0,041  Shock treatment
0,101  0,004  Membrane dipeptidase inhibitor
0,202  0,106  Acute neurologic disorders treatment
0,151  0,055  Toll-Like receptor antagonist
0,126  0,031  Alcohol dehydrogenase inhibitor
0,149  0,053  Farnesoid X receptor antagonist
0,148  0,052  Antiprotozoal (Trichomonas)
0,231  0,137  Antiallergic
0,129  0,035  HIV-1 integrase (Overall Integration) inhibitor
0,099  0,006  Mannosidase inhibitor
0,131  0,038  Sulfotransferase substrate
0,113  0,019  GABA aminotransferase inhibitor
0,114  0,021  Matrix metalloproteinase inhibitor
0,113  0,021  Granulocyte macrophage colony stimulating factor agonist
0,194  0,102  Free radical scavenger
0,133  0,042  Antiviral (CMV)
0,173  0,082  LDLR expression enhancer
0,148  0,057  Nav1.6 sodium channel blocker
0,141  0,051  Adenylate cyclase inhibitor
0,127  0,037  DOPA decarboxylase inhibitor
0,122  0,034  Calcium antagonist
0,153  0,066  Lipid peroxidase inhibitor
0,091  0,004  Geranyltranstransferase inhibitor
0,138  0,052  Antiprotozoal (Amoeba)
0,129  0,043  Xanthine oxidase inhibitor
0,120  0,036  Electrolyte absorption antagonist
0,125  0,041  Carbonic anhydrase III inhibitor
0,135  0,051  Antiviral (Papilloma)
0,098  0,015  Androgen agonist
0,095  0,012  Carbonic anhydrase XIV inhibitor
0,195  0,114  Vascular (periferal) disease treatment
0,125  0,044  Protease inhibitor
0,139  0,058  Antihemorrhagic
0,087  0,007  Lysophosphatidic acid 3 receptor antagonist
0,137  0,059  Antibacterial (Helicobacter pylori)
0,100  0,022  Leukotriene antagonist
0,093  0,015  Glutamate (mGluR7) antagonist
0,097  0,020  Ribonucleoside-diphosphate reductase inhibitor
0,098  0,021  Ribonucleotide reductase inhibitor
0,143  0,066  Heat shock protein 70 antagonist
0,112  0,035  Antiviral (Rhinovirus)
0,092  0,016  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,107  0,031  Antibiotic
0,094  0,018  Antidote, heavy metal
0,084  0,009  Kainate receptor antagonist
0,080  0,005  Sphingosine kinase 1 inhibitor
0,092  0,016  Matrix metalloproteinase (membrane-type) inhibitor
0,081  0,006  Kainate receptor 2 antagonist
0,079  0,004  Peptide deformylase inhibitor
0,155  0,081  Interleukin 6 antagonist
0,089  0,015  Thromboxane antagonist
0,094  0,020  Carbonic anhydrase stimulant
0,122  0,048  Myasthenia Gravis treatment
0,107  0,033  Porphobilinogen synthase inhibitor
0,142  0,069  Histone deacetylase SIRT1 inhibitor
0,126  0,053  Cystathionine beta-synthase inhibitor
0,111  0,039  Carcinogenic, group 2A
0,077  0,005  Cytokine production stimulant
0,086  0,014  Antibiotic Glycopeptide-like
0,077  0,006  Prostacyclin antagonist
0,078  0,007  Nicotinic acid receptor agonist
0,097  0,027  SULT1A2 substrate
0,084  0,014  Sphingosine 1-phosphate receptor 3 antagonist
0,088  0,018  Antimetabolite
0,088  0,018  Antimycoplasmal
0,108  0,039  Phosphodiesterase 6D inhibitor
0,096  0,027  Phenylalanine 4-hydroxylase inhibitor
0,091  0,023  Anticholelithogenic
0,111  0,043  Tourette's syndrome treatment
0,178  0,110  Antialcoholic
0,179  0,112  Cyclic AMP phosphodiesterase inhibitor
0,077  0,010  Adenosine deaminase inhibitor
0,086  0,019  Matrix metalloproteinase 1 inhibitor
0,077  0,010  Adenine nucleotide translocase inhibitor
0,134  0,068  Skin whitener
0,089  0,023  Phospholipase D inhibitor
0,091  0,026  Hyperparathyroidism treatment
0,198  0,133  Cardioprotectant
0,074  0,009  Squalene synthetase inhibitor
0,092  0,028  Sphingosine 1-phosphate receptor antagonist
0,087  0,023  Biliverdin reductase inhibitor
0,069  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,095  0,031  Peroxisome proliferator-activated receptor gamma agonist
0,104  0,041  Bile acid receptor antagonist
0,073  0,009  Sphingosine 1-phosphate receptor 3 agonist
0,078  0,015  Postcoital contraceptive
0,123  0,059  Menstruation disorders treatment
0,146  0,083  Protein-tyrosine phosphatase inhibitor
0,067  0,005  Kainate receptor agonist
0,100  0,038  Antileprosy
0,070  0,008  Arginase inhibitor
0,100  0,038  Metalloproteinase-2 inhibitor
0,075  0,013  5-Alpha-reductase inhibitor
0,068  0,006  Glutamate (mGluR3) antagonist
0,089  0,027  GABA B receptor agonist
0,122  0,061  Protein-tyrosine phosphatase 1B inhibitor
0,079  0,018  Peroxisome proliferator-activated receptor alpha agonist
0,064  0,004  Thyroid hormone alpha antagonist
0,074  0,015  Thromboxane synthase inhibitor
0,069  0,009  Sphingosine 1-phosphate receptor 1 agonist
0,140  0,081  Hemostatic
0,237  0,178  Atherosclerosis treatment
0,062  0,003  Prostaglandin F2 alpha agonist
0,091  0,033  Narcotic antagonist
0,061  0,003  Lysophosphatidic acid receptor 1 agonist
0,115  0,057  Acetylcholine release stimulant
0,079  0,023  Nitric oxide donor
0,068  0,012  Sphingosine 1-phosphate receptor agonist
0,061  0,005  Cholesterol absorption inhibitor
0,086  0,030  Glucagon-like peptide 1 agonist
0,181  0,125  Antineoplastic (renal cancer)
0,062  0,006  Delayed rectifier potassium channel blocker
0,061  0,006  Lysophosphatidic acid 2 receptor antagonist
0,110  0,055  Carbonic anhydrase XV inhibitor
0,230  0,176  Antiobesity
0,080  0,027  Protease 3C (Human rhinovirus) inhibitor
0,068  0,016  Pregnane X receptor antagonist
0,071  0,019  Metalloproteinase-3 inhibitor
0,063  0,011  Neuraminidase (Influenza A) inhibitor
0,071  0,020  Lipocortins synthesis agonist
0,196  0,145  Transcription factor STAT inhibitor
0,109  0,059  Antiprotozoal (Toxoplasma)
0,111  0,061  Nav1.4 sodium channel blocker
0,069  0,020  Leukotriene B4 antagonist
0,146  0,098  Antianginal
0,060  0,012  Guanylate cyclase inhibitor
0,072  0,025  Corticotropin releasing factor 2 receptor antagonist
0,173  0,126  5 Hydroxytryptamine 3E antagonist
0,064  0,018  HCV NS3/NS4A protease inhibitor
0,051  0,005  Kainate receptor 1 antagonist
0,070  0,024  Prostaglandin E2 antagonist
0,076  0,031  SULT2A1 substrate
0,050  0,005  Excitatory amino acid transporter 2 inhibitor
0,054  0,009  Prostaglandin agonist
0,050  0,005  Glutamate (mGluR3) agonist
0,088  0,043  Antiviral (Dengue virus)
0,047  0,003  Lysophosphatidic acid receptor 3 agonist
0,056  0,012  GABA uptake inhibitor
0,061  0,016  Oxytocin agonist
0,055  0,011  Angiotensin AT1 receptor antagonist
0,124  0,080  Interleukin 4 antagonist
0,078  0,033  Neutrophil collagenase inhibitor
0,054  0,010  Retinoid X receptor antagonist
0,064  0,021  Leukotriene C antagonist
0,055  0,012  Fumarate hydratase inhibitor
0,073  0,029  Hypercalcemia treatment
0,073  0,029  Collagenase 3 inhibitor
0,070  0,026  Estrogen agonist
0,105  0,063  Antifungal (Aspergillus)
0,100  0,058  Interleukin 1 beta converting enzyme inhibitor
0,045  0,004  Hedgehog signaling activator
0,074  0,033  Uterine relaxant
0,045  0,003  Vanilloid 2 agonist
0,045  0,004  Nicotinic acid receptor 2 antagonist
0,137  0,096  Neuropathy treatment
0,092  0,051  Tocolytic
0,049  0,008  Uridine phosphorylase inhibitor
0,048  0,008  Ceramide glucosyltransferase inhibitor
0,056  0,016  Glutamate (mGluR4) antagonist
0,055  0,016  Retinoid X receptor agonist
0,046  0,007  Prostaglandin EP1 antagonist
0,063  0,024  Sphingosine 1-phosphate receptor 1 antagonist
0,061  0,022  Immunoglobulin Fc receptor antagonist
0,091  0,053  Interleukin 5 antagonist
0,054  0,015  Renin inhibitor
0,046  0,008  Lysine carboxypeptidase inhibitor
0,081  0,043  Cathepsin G inhibitor
0,050  0,012  Peroxisome proliferator-activated receptor delta agonist
0,054  0,016  Thymidine kinase inhibitor
0,116  0,078  Bipolar disorder treatment
0,046  0,009  Retinoid X alpha receptor antagonist
0,053  0,016  Plasmepsin II inhibitor
0,080  0,043  Antitreponemal
0,040  0,003  Neuraminidase (Influenza B) inhibitor
0,039  0,003  Vitamin D receptor agonist
0,076  0,040  Elastase 1 inhibitor
0,045  0,009  Prostaglandin EP4 antagonist
0,040  0,004  1,3-Beta-glucan synthase inhibitor
0,045  0,010  Angiotensin II receptor antagonist
0,038  0,003  Isoleucine-tRNA ligase inhibitor
0,071  0,036  MDM2 inhibitor
0,045  0,010  HMG CoA reductase inhibitor
0,056  0,022  Purinergic P2Y antagonist
0,050  0,017  Calcitonin receptor agonist
0,042  0,008  Prostaglandin EP2 agonist
0,044  0,010  Prostaglandin D2 agonist
0,059  0,025  Bombesin 2 receptor antagonist
0,045  0,012  Free fatty acid receptor 1 antagonist
0,070  0,037  Antiemphysemic
0,041  0,009  Calcium-independent phospholipase A2 inhibitor
0,047  0,014  Glutamate (mGluR8) agonist
0,043  0,011  GABA transporter 3 inhibitor
0,039  0,007  Purinergic P2Y15 antagonist
0,043  0,011  ATP citrate lysase inhibitor
0,058  0,026  Vanilloid 2 antagonist
0,061  0,029  Acetyl-CoA transferase inhibitor
0,056  0,025  Neurotensin receptor antagonist
0,059  0,028  Nicotinic alpha3beta2 receptor antagonist
0,068  0,037  Cannabinoid CB1 receptor agonist
0,037  0,007  Estrogen-related receptor gamma antagonist
0,068  0,038  Beta 3 adrenoreceptor antagonist
0,047  0,018  AMPA 4 receptor antagonist
0,041  0,012  Carboxypeptidase B inhibitor
0,136  0,108  Liver fibrosis treatment
0,049  0,021  Glutamate (mGluR group III) antagonist
0,034  0,006  Vitamin D receptor antagonist
0,032  0,004  Carbonic anhydrase X inhibitor
0,032  0,004  Carbonic anhydrase VIII inhibitor
0,059  0,031  Angiotensin-converting enzyme inhibitor
0,040  0,012  Hypoxanthine phosphoribosyltransferase inhibitor
0,050  0,023  Leukocyte elastase inhibitor
0,066  0,039  NMDA receptor agonist
0,031  0,005  Toll-Like receptor 8 agonist
0,082  0,057  CC chemokine 5 receptor agonist
0,218  0,193  Antineoplastic (endocrine cancer)
0,052  0,027  Potassium channel Kv1.3 blocker
0,050  0,025  Antiviral (Enterovirus)
0,046  0,021  Dopamine D5 agonist
0,056  0,031  Heparanase inhibitor
0,062  0,037  Cathepsin E inhibitor
0,052  0,027  Cholesterol esterase inhibitor
0,059  0,034  Acetyl-CoA transferase 2 inhibitor
0,042  0,018  Vanilloid 3 antagonist
0,085  0,060  Hematopoietic
0,127  0,103  Antidiarrheal
0,038  0,014  Methionyl aminopeptidase 1 inhibitor
0,029  0,005  Ileal bile acid transport inhibitor
0,040  0,016  Sodium-dependent vitamin C transporter 2 inhibitor
0,045  0,022  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,050  0,027  Carbonic anhydrase VII inhibitor
0,041  0,018  Phosphoglycerate kinase inhibitor
0,028  0,005  Retinoid X beta receptor antagonist
0,056  0,034  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,031  0,008  Acid ceramidase inhibitor
0,028  0,005  Excitatory amino acid transporter 3 inhibitor
0,042  0,020  Leukotriene C4 antagonist
0,069  0,046  Sirtuin 1 inhibitor
0,026  0,004  Telomerase stimulant
0,062  0,041  Purinergic P2X1 antagonist
0,053  0,032  Prolyl endopeptidase inhibitor
0,060  0,039  Xanthine dehydrogenase inhibitor
0,120  0,099  Antieczematic
0,066  0,045  Beta adrenoreceptor antagonist
0,039  0,018  Glutamate (mGluR8) antagonist
0,073  0,053  NAT1 substrate
0,072  0,052  Lipase inhibitor
0,025  0,005  Excitatory amino acid transporter 1 inhibitor
0,025  0,005  Estrogen-related receptor gamma agonist
0,053  0,034  Thromboxane A2 antagonist
0,054  0,035  Sphingosine 1-phosphate receptor 5 agonist
0,027  0,008  Lysophosphatidic acid 1 receptor antagonist
0,035  0,016  Glucagon receptor antagonist
0,023  0,004  Thromboxane A2 agonist
0,062  0,043  Beta 2 adrenoreceptor agonist
0,093  0,075  Gastric antisecretory
0,055  0,037  Cathepsin D inhibitor
0,070  0,053  Peroxisome proliferator-activated receptor gamma antagonist
0,029  0,013  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,046  0,030  Fructose-1,6-bisphosphatase inhibitor
0,056  0,040  Beta 1 adrenoreceptor antagonist
0,052  0,036  Carbonic anhydrase II stimulant
0,063  0,047  Calcium channel P-type blocker
0,096  0,080  Antihelmintic (Fasciola)
0,023  0,007  Prostacyclin agonist
0,042  0,027  Acetyl-CoA transferase 1 inhibitor
0,047  0,032  Endothelin-converting enzyme inhibitor
0,132  0,118  Movement disorders treatment
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,059  0,044  Phosphodiesterase 1A inhibitor
0,037  0,022  Retinoid X alpha receptor agonist
0,036  0,022  Adenosine uptake inhibitor
0,018  0,005  Antineoplastic (insulinoma)
0,031  0,017  Leukotriene B4 receptor 1 antagonist
0,069  0,055  Epoxide hydrolase inhibitor
0,050  0,037  Beta 2 adrenoreceptor antagonist
0,021  0,008  Methylmalonyl-CoA mutase inhibitor
0,076  0,063  Carbonic anhydrase VI inhibitor
0,026  0,013  Prostaglandin E2 agonist
0,017  0,005  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,032  0,020  Cholesterol ester transfer protein antagonist
0,066  0,054  Exportin-1 inhibitor
0,053  0,041  Neuropeptide agonist
0,025  0,013  Neutral endopeptidase inhibitor
0,084  0,073  Thioredoxin inhibitor
0,016  0,004  Thromboxane agonist
0,026  0,015  Glutamate (mGluR1) agonist
0,064  0,053  Potassium channel (ATP-sensitive) blocker
0,056  0,045  Prostaglandin EP2 antagonist
0,027  0,016  Prostaglandin H2 antagonist
0,035  0,025  Nociceptin (N/OFQ) receptor antagonist
0,016  0,005  Calcium-dependent phospholipase A2 inhibitor
0,021  0,010  Aminopeptidase A inhibitor
0,042  0,031  HIV-1 protease inhibitor
0,103  0,092  Cholinergic antagonist
0,024  0,014  Monocarboxylic acid transporter inhibitor
0,024  0,014  Monocarboxylic acid transporter 1 inhibitor
0,074  0,064  MAP kinase kinase 7 inhibitor
0,058  0,048  NMDA 2C receptor antagonist
0,119  0,109  Acetylcholine M1 receptor antagonist
0,024  0,014  ICAM 1 antagonist
0,082  0,073  ATPase (Vacuolar H+) inhibitor
0,044  0,035  Adenylate cyclase 1 inhibitor
0,034  0,025  Purinergic P2X3 antagonist
0,129  0,120  Nitric oxide antagonist
0,018  0,009  Adenosine A2 receptor agonist
0,013  0,005  Angiotensin AT2 receptor agonist
0,019  0,011  5-Alpha-reductase 1 inhibitor
0,057  0,049  NMDA receptor glycine site agonist
0,020  0,012  Apical sodium codependent bile acid transporter inhibitor
0,070  0,062  Potassium channel (Tandem pore domain) blocker
0,026  0,018  Toll-Like receptor 4 agonist
0,079  0,071  D-Ala-D-Ala ligase inhibitor
0,025  0,017  Sodium/glucose cotransporter 1 inhibitor
0,059  0,052  Histone deacetylase SIRT3 inhibitor
0,059  0,052  Purinergic P2X2 antagonist
0,023  0,016  Fructose-1,6-bisphosphatase 1 inhibitor
0,091  0,084  HDL-cholesterol increasing
0,076  0,070  Antiprotozoal activity enhancer
0,033  0,026  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,059  0,052  Phosphodiesterase 1C inhibitor
0,043  0,037  Microtubule stabilization
0,016  0,010  Purinergic P2Y1 agonist
0,019  0,014  Antibiotic Anthracycline-like
0,078  0,073  mTOR complex 2 inhibitor
0,087  0,082  Chronic obstructive bronchitis treatment
0,128  0,123  Dual specificity phosphatase inhibitor
0,019  0,014  Caspase 8 inhibitor
0,115  0,110  Pancreatic disorders treatment
0,143  0,138  Phobic disorders treatment
0,080  0,076  Phosphodiesterase I inhibitor
0,014  0,010  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,100  0,096  Interleukin 8 antagonist
0,069  0,065  Phosphodiesterase VI inhibitor
0,017  0,013  Nicotinic acid receptor 1 antagonist
0,019  0,015  Retinoic acid beta receptor agonist
0,070  0,067  Estrogen receptor alpha antagonist
0,047  0,044  Protein 50S ribosomal subunit inhibitor
0,052  0,048  Cathepsin L inhibitor
0,102  0,099  Mental retardation treatment
0,047  0,043  Potassium channel (Inward rectifier) activator
0,026  0,023  Baculoviral IAP repeat-containing protein 4 inhibitor
0,080  0,077  Aminoacyl-tRNA synthetase inhibitor
0,045  0,042  Potassium channel (ATP-sensitive) activator
0,160  0,157  DNA damaging
0,098  0,096  Autism spectrum disorders treatment
0,024  0,022  Sodium/glucose cotransporter inhibitor
0,040  0,039  Dihydroorotase inhibitor
0,027  0,026  Plasmepsin I inhibitor
0,010  0,010  Immunosuppressant Cyclosporine-like
0,011  0,010  Purine nucleoside phosphorylase inhibitor
0,030  0,030  Melatonin receptor 1A agonist
0,024  0,024  Sodium/glucose cotransporter 2 inhibitor

